CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 97 filers reported holding CYTOKINETICS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,632,000 | +31.8% | 134,303 | -0.4% | 0.00% | 0.0% |
Q3 2016 | $1,238,000 | +0.8% | 134,826 | +4.2% | 0.00% | 0.0% |
Q2 2016 | $1,228,000 | +36.1% | 129,386 | +1.1% | 0.00% | +100.0% |
Q1 2016 | $902,000 | -32.1% | 127,988 | +0.7% | 0.00% | -50.0% |
Q4 2015 | $1,329,000 | +57.8% | 127,055 | +0.9% | 0.00% | +100.0% |
Q3 2015 | $842,000 | -3.2% | 125,895 | -2.8% | 0.00% | 0.0% |
Q2 2015 | $870,000 | +12.1% | 129,536 | +13.2% | 0.00% | 0.0% |
Q1 2015 | $776,000 | -15.9% | 114,474 | -0.6% | 0.00% | 0.0% |
Q4 2014 | $923,000 | +124.0% | 115,217 | -1.6% | 0.00% | 0.0% |
Q3 2014 | $412,000 | -24.0% | 117,069 | +3.2% | 0.00% | 0.0% |
Q2 2014 | $542,000 | -38.9% | 113,429 | +21.4% | 0.00% | 0.0% |
Q1 2014 | $887,000 | +77.8% | 93,408 | +21.7% | 0.00% | 0.0% |
Q4 2013 | $499,000 | -15.4% | 76,766 | -1.5% | 0.00% | 0.0% |
Q3 2013 | $590,000 | – | 77,970 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |